EX-99.1 2 tm2534375d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Amended Loan Schedule to Secured Promissory Note dated November 10, 2022

between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

 

   Date   Principal   Aggregated
Principal		 
  Original Secured Promissory Note   11/10/2022   $2,319,279   $2,319,279 
  Additional Loans to be included:               
               Loans #1 dated 12/22/2022 through Loan #38 dated 6/20/2025       $5,875,000   $8,194,279 
               Loan #39   7/03/2025   $100,000   $8,294,279 
               Loan #40   7/18/2025   $100,000   $8,394,279 
               Loan #41   8/01/2025   $100,000   $8,494,279 
               Loan #42   8/15/2025   $100,000   $8,594,279 
               Loan #43   9/03/2025   $100,000   $8,694,279 
               Loan #44   9/12/2025   $100,000   $8,794,279 
               Loan #45   10/06/2025   $100,000   $8,894,279 
               Loan #46   10/23/2025   $100,000   $8,994,279 
               Loan #47   11/12/2025   $100,000   $9,094,279 
               Loan #48   11/21/2025   $100,000   $9,194,279 
               Loan #49   12/12/2025   $100,000   $9,294,279 

 

ACURA PHARMACEUTICALS, INC.

 

By: /s/ Robert A. Seiser

Robert A. Seiser

Senior Vice President & CFO

Date: December 12, 2025

 

 

 1